Disruption of the Plasmodium falciparum Life Cycle through Transcriptional Reprogramming by Inhibitors of Jumonji Demethylases. Academic Article uri icon

Overview

abstract

  • Little is known about the role of the three Jumonji C (JmjC) enzymes in Plasmodium falciparum (Pf). Here, we show that JIB-04 and other established inhibitors of mammalian JmjC histone demethylases kill asexual blood stage parasites and are even more potent at blocking gametocyte development and gamete formation. In late stage parasites, JIB-04 increased levels of trimethylated lysine residues on histones, suggesting the inhibition of P. falciparum Jumonji demethylase activity. These epigenetic defects coincide with deregulation of invasion, cell motor, and sexual development gene programs, including gene targets coregulated by the PfAP2-I transcription factor and chromatin-binding factor, PfBDP1. Mechanistically, we demonstrate that PfJmj3 converts 2-oxoglutarate to succinate in an iron-dependent manner consistent with mammalian Jumonji enzymes, and this catalytic activity is inhibited by JIB-04 and other Jumonji inhibitors. Our pharmacological studies of Jumonji activity in the malaria parasite provide evidence that inhibition of these enzymatic activities is detrimental to the parasite.

publication date

  • April 24, 2020

Research

keywords

  • Aminopyridines
  • Hydrazones
  • Jumonji Domain-Containing Histone Demethylases
  • Plasmodium falciparum

Identity

PubMed Central ID

  • PMC7748244

Scopus Document Identifier

  • 85084721111

Digital Object Identifier (DOI)

  • 10.1021/acsinfecdis.9b00455

PubMed ID

  • 32272012

Additional Document Info

volume

  • 6

issue

  • 5